Total Knee Arthroplasty Implant (Scorpio®)
DeviceImplantation of a Total Knee Arthroplasty using Conventional Intramedullary Instrumentation
Other names: Scorpio Total Knee Arthroplasty
NCT Number: NCT00830986
A significant number of patients experience postoperative cognitive changes following total joint arthroplasty. Among other causes, the mental status change may be the result of fat and bone marrow debris embolization. We hypothesized that the use of computer assisted total knee arthroplasty, which does not utilize intramedullary alignment rods, would produce less fat and bone marrow debris embolization and, hence, fewer mental status changes.
Looking for future studies?
Notify MeAll sexes
Observational
Inclusion criteria
Exclusion criteria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Implantation of a Total Knee Arthroplasty using Conventional Intramedullary Instrumentation
Other names: Scorpio Total Knee Arthroplasty
Time frame: 6 Months Post-Operative
Rothman Institute Orthopaedics
Other
Cognition Following Computer Assisted Total Knee Arthroplasty: A Prospective Cohort Study
Acronym: Minimental
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05912556
Brain Function, Brain Health
San Francisco, California, United States
View Trial DetailsNCT07047105
Cognition, Fatigue
Newcastle upon Tyne, United Kingdom
View Trial DetailsNCT07387523
Brain Health Activities, Cognition
Barcelona, Catalonia, Spain
View Trial DetailsNCT06995560
Brain Stimulation, Cognition
Charlestown, Massachusetts, United States
View Trial Details